Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
주식 순위 #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
주가
$2.20
마지막 동기화: 2026-09-01
시가총액
$253.81M
변동 (1일)
10.29%
변동 (1년)
99.67%
국가
CA
거래 Cardiol Therapeutics Inc. (CRDL)

카테고리

Cardiol Therapeutics Inc. (CRDL)의 주식 분할 이력
Cardiol Therapeutics Inc. 주식 (심볼: CRDL)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Sep 02, 2026에 발생했습니다.
Sep 02, 2026 이전에 매수한 CRDL 주식 1주는 현재 0주의 CRDL 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할